ArticleInfection and immunity2021
Influenza Virus Infection Impairs the Gut's Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids.
Open access · greenAbstract read
In one paragraph
Article in Infection and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.
0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
62 citing papers in PubMed, 85 citations in OpenAlex.
- Therapeutic effects of Lentinan in gastrointestinal inflammation and carcinogenesis - A scoping review of evidence from preclinical and clinical studies.European journal of microbiology & immunology · 2026Review
- Gut microbiota-derived short-chain fatty acids (SCFAs): immunomodulatory effects and therapeutic potential in infections.Clinical microbiology reviews · 2026Review
- Kai-Bi-Bu-Fei Decoction Protects Mice Against Influenza Virus-Induced Severe Pneumonia via Gut Microbiota-Short Chain Fatty Acid Axis.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Senolytic Treatment Reduces Acute and Chronic Lung Inflammation in an Aged Mouse Model of Influenza.Aging cell · 2026Article
- Article
- Lactiplantibacillus plantarum GUANKE Alleviates Intestinal Barrier Damage Caused by Influenza Infection in Mice.Probiotics and antimicrobial proteins · 2026Article
- Interplay between viral infections and gut microbiota dysbiosis: Mechanisms and therapeutic potential.World journal of gastroenterology · 2026Review
- Oral fermented rice bran supplementation suppresses viral replication and stimulates immune functions in immunocompetent and immunocompromised mice infected with influenza virus.BMC complementary medicine and therapies · 2026Article
- Fiber-deprived diet weakens lung defense against antimicrobial-resistantGut microbes reports · 2026Article
- Omics Approaches to Unraveling the Complexity of the Gut-Lung Axis.Methods in molecular biology (Clifton, N.J.) · 2026Review
- Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19.Gut microbes · 2025Article
- Altered gut microbial functional pathways in people with irritable bowel syndrome enable precision health insights.BMC gastroenterology · 2025Article
- Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.Research square · 2025Article
- Early-Life Events and the Prevalence of Gut-Brain Interaction Disorders in Children.Children (Basel, Switzerland) · 2025Article
- Review
- Gastrointestinal Infiltration in Influenza Virus Infection: Mechanisms and Clinical Insights.Viruses · 2025Review
- Article
- The Role of Gut Microbiota in the Modulation of Pulmonary Immune Response to Viral Infection Through the Gut-Lung Axis.Journal of inflammation research · 2025Review
- Intestinal barrier function as a key determinant of inflammation and nutritional status in digestive surgery patients: a real-world study.Frontiers in nutrition · 2025Article
- Short-chain fatty acids: key antiviral mediators of gut microbiota.Frontiers in immunology · 2025Review
2 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 4 institutions in 2 countries.
Valentin SencioUniversité Lille, US 41, UMS 2014, PLBS, U1019, UMR 9017, CIIL, Centre d'Infection et d'Immunité de Lille, Lille, France.
Alexandre GallerandCentre Méditerranéen de Médecine Moléculaire (C3M), Institut National de la Santé et de la Recherche Médicale U1065, Université Côte d'Azur, Nice, France.
Marina Gomes MachadoUniversité Lille, US 41, UMS 2014, PLBS, U1019, UMR 9017, CIIL, Centre d'Infection et d'Immunité de Lille, Lille, France.
Lucie DeruyterUniversité Lille, US 41, UMS 2014, PLBS, U1019, UMR 9017, CIIL, Centre d'Infection et d'Immunité de Lille, Lille, France.
Séverine HeumelUniversité Lille, US 41, UMS 2014, PLBS, U1019, UMR 9017, CIIL, Centre d'Infection et d'Immunité de Lille, Lille, France.
Daphnée SoulardUniversité Lille, US 41, UMS 2014, PLBS, U1019, UMR 9017, CIIL, Centre d'Infection et d'Immunité de Lille, Lille, France.
Johanna BarthelemyUniversité Lille, US 41, UMS 2014, PLBS, U1019, UMR 9017, CIIL, Centre d'Infection et d'Immunité de Lille, Lille, France.
Céline CuinatMicalis Institute, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement UMR1319, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Angelica T VieiraCentre Méditerranéen de Médecine Moléculaire (C3M), Institut National de la Santé et de la Recherche Médicale U1065, Université Côte d'Azur, Nice, France.
Adeline BarthelemyUniversité Lille, US 41, UMS 2014, PLBS, U1019, UMR 9017, CIIL, Centre d'Infection et d'Immunité de Lille, Lille, France.
Luciana P TavaresCentre Méditerranéen de Médecine Moléculaire (C3M), Institut National de la Santé et de la Recherche Médicale U1065, Université Côte d'Azur, Nice, France.
Rodolphe GuinamardInstituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Stoyan IvanovInstituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Corinne GrangetteUniversité Lille, US 41, UMS 2014, PLBS, U1019, UMR 9017, CIIL, Centre d'Infection et d'Immunité de Lille, Lille, France.
Mauro M TeixeiraCentre Méditerranéen de Médecine Moléculaire (C3M), Institut National de la Santé et de la Recherche Médicale U1065, Université Côte d'Azur, Nice, France.
Benoit FolignéUniversité Lille, INSERM, CHU Lille, U995, Lille Inflammation Research International Center (LIRIC), Lille, France.
Isabelle WolowczukUniversité Lille, US 41, UMS 2014, PLBS, U1019, UMR 9017, CIIL, Centre d'Infection et d'Immunité de Lille, Lille, France.
Ronan Le GofficUniversité Paris-Saclay, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement UR892, UVSQ, VIM, Jouy-en-Josas, France.
Muriel ThomasMicalis Institute, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement UMR1319, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
François TrotteinUniversité Lille, US 41, UMS 2014, PLBS, U1019, UMR 9017, CIIL, Centre d'Infection et d'Immunité de Lille, Lille, France.
Inserm · FRAgroParisTech · FRUniversidade Federal de Minas Gerais · BRUniversité de Versailles Saint-Quentin-en-Yvelines · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
Along with respiratory tract disease
Indexed as
Host-Pathogen InteractionsMicrobial InteractionsDisease SusceptibilityDysbiosisEnterobacteriaceae InfectionsFatty Acids, VolatileHumansInfluenza A virusInfluenza, HumanIntestinal MucosaFatty Acids, Volatilebacterial translocationenteric infectiongut microbial dysbiosisinfluenzashort-chain fatty acids
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.